These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 6329078

  • 1. In vitro susceptibilities of human and wild-type isolates of Basidiobolus and Conidiobolus species.
    Yangco BG, Okafor JI, TeStrake D.
    Antimicrob Agents Chemother; 1984 Apr; 25(4):413-6. PubMed ID: 6329078
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole.
    Ahearn DG, McGlohn MS.
    J Clin Microbiol; 1984 Mar; 19(3):412-6. PubMed ID: 6325491
    [Abstract] [Full Text] [Related]

  • 4. In-vitro antifungal susceptibilities of Basidiobolus and Conidiobolus spp. strains.
    Guarro J, Aguilar C, Pujol I.
    J Antimicrob Chemother; 1999 Oct; 44(4):557-60. PubMed ID: 10588321
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vitro susceptibility of Cryptococcus neoformans isolates from patients with acquired immunodeficiency syndrome.
    Poon M, Cronin DC, Wormser GP, Bottone EJ.
    Arch Pathol Lab Med; 1988 Feb; 112(2):161-2. PubMed ID: 3276290
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Synergic effect of 5-fluorocytosine and imidazole derivatives against yeast strains resistant to 5-fluorocytosine].
    Mary C, Goudard M, Blancard A, Quilici M, Regli P.
    Ann Biol Clin (Paris); 1989 Feb; 47(9):546-9. PubMed ID: 2558599
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents.
    Denning DW, Hanson LH, Perlman AM, Stevens DA.
    Diagn Microbiol Infect Dis; 1992 Jan; 15(1):21-34. PubMed ID: 1309690
    [Abstract] [Full Text] [Related]

  • 14. [In vitro susceptibility of Cryptococcus strains to 5 antifungal drugs].
    Bava AJ, Negroni R.
    Rev Inst Med Trop Sao Paulo; 1989 Jan; 31(5):346-50. PubMed ID: 2560840
    [Abstract] [Full Text] [Related]

  • 15. Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts.
    Doern GV, Tubert TA, Chapin K, Rinaldi MG.
    J Clin Microbiol; 1986 Oct; 24(4):507-11. PubMed ID: 3533974
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Susceptibility to 5-fluorocytosine, miconazole and amphotericin B of Candida albicans strains isolated from the throat of non-AIDS patients.
    Paniagua GL, Monroy E, Negrete E, Vaca S.
    Rev Latinoam Microbiol; 2002 Oct; 44(2):65-8. PubMed ID: 17063773
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In vitro susceptibility studies with oxiconazole (Ro 13-8996).
    Gebhart RJ, Espinel-Ingroff A, Shadomy S.
    Chemotherapy; 1984 Oct; 30(4):244-7. PubMed ID: 6086246
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.